Swiss cannabis & hemp import / export
Customs volumes for hemp/CBD products (< 1% THC) and medical cannabis actives. Tonnes / year.
Key facts
- CBD hemp exports 2025: ≈ 120 t
- Key target markets: DE, AT, IT, PL
- Medical import 2025: ≈ 340 kg
Key takeaways
- Switzerland exported roughly 120 t of hemp/CBD goods in 2025, mainly to Germany, Austria, Italy and Poland.
- Medical cannabis flows the other way: about 340 kg imported in 2025.
- A CBD export surplus stands against a structural import deficit for pharmaceutical-grade product.
Interpretation
Trade data shows Switzerland's split role: net exporter of CBD raw material, net importer of GMP-certified medical cannabis. The reason is certification rather than agronomy — GMP capacity is expensive and scarce in Switzerland. Germany's partial legalisation lifted export demand short-term but leaves Swiss production exposed once EU growers match the quality at lower cost.
Limitations
- Customs tariff codes do not always separate CBD hemp from industrial hemp.
- Re-exports can appear on both sides of the flow.
- Small postal shipments are not statistically recorded.
Data
| Destination | Export share |
|---|---|
| Deutschland | 38 |
| Österreich | 18 |
| Italien | 15 |
| Polen | 10 |
| Andere EU | 19 |
Methodology
Swiss-Impex tariff codes 1211.9010 (hemp) and 2939.79 (cannabinoids). Medical cannabis via Swissmedic quota reports.
Sources
- BAZG — Swiss-Impex Zollstatistik — BAZG
- Swissmedic — Kontingente Betäubungsmittel — Swissmedic
Related data & articles
Parent
Related datasets
- Swiss CBD & cannabis market size — Dataset · Market
- Medical cannabis in Switzerland — prescriptions & growth — Dataset · Medical
Matching knowledge hubs
- Cannabis statistics Switzerland — Knowledge hub
- CBD — The complete Switzerland hub — Knowledge hub